Reaction profile

The FDA adverse-event record for acid-base disorder

108 FDA adverse-event reports reference acid-base disorder (VeDDRA 540). Plate codes and volume neighbourhood below; species, breeds, and drugs follow.

#1349 of 2,481
by report volume (all reactions)
108
reports citing this reaction
31.5%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Acid-base disorder has 108 reports now versus 101 in that prior snapshot: 7 more (6.9%).

Report change
+7
Death-coded reports
+1
Death-coded share
−1.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Acid-base disorder changes

FDA AER · VeDDRA plate

Code 540 VOL-LOW

VOL-LOW · DEATH-HOT · MID-PACK · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-LOW 108 reports
  • DEATH-HOT 31.5%
  • MID-PACK #1349/2481
  • PHOTO-FINISH Discus prolapse
  • SPECIES-DOG Dog · 54
  • DRUG-LEAD Velagliflozin Pro… · 35
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Discus prolapse (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Report-volume neighbourhood around Acid-base disorder

Highest and lowest poles plus nearest volume peers, not a full 2,500-reaction corpus board reprint.

Vomiting · highest174348Acid-base disorder · this re…108Discus prolapse · near108Heart pounding · near108Lick granuloma · near108Nasal cavity and sinu… · near108Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Acid-base disorder

Acid-base disorder: high death-coded share in the FDA AER plate

Signature read: Acid-base disorder's 31.5% death-coded share is among the highest in the openFDA reaction corpus. Report volume sits in the middle third of the reaction corpus. Death-coded share is upper-third: 34 of 108 reports (31.5% of named reports). Nearest volume peer: Discus prolapse (±0 reports). Lead species Dog (54). Lead co-reported drug Velagliflozin Proline Monohydrate (35).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 54
Cat 50
Other 2
Horse 1
Pig 1

Breeds Most Affected

Domestic Shorthair 36
Domestic Longhair 5
Unknown 4
Domestic Mediumhair 4
Retriever - Labrador 3
Chihuahua 3
Retriever - Golden 3
Beagle 3
Dog (other) 2
Shepherd Dog - German 2

Associated Drugs

Velagliflozin Proline Monohydrate 35
Carprofen 14
Gabapentin 10
Propofol 8
Afoxolaner 7
Enrofloxacin 6
Midazolam 6
Isoflurane 6
Diphenhydramine 6
Butorphanol 6
Milbemycin Oxime + Spinosad 5
Ivermectin + Pyrantel As Pamoate Salt 5
Ketamine 5
Dexmedetomidine 5
Maropitant 5
Famotidine 5
Tigilanol Tiglate 5
Oxygen 4
Lidocaine 4
Morphine 4

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Acid-base disorder, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (108 here).

Similar death-coded share

Nearest other reactions by death-coded share (31.5% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Acid-base disorder (#1349 of 2,481 by report volume); death-coded 31.5%. PlainBreed reaction plate · death-coded share stamp 31.5% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →